AAAAAA

   
Results: 1-3 |
Results: 3
ABILITY OF A FIRST-PASS PHARMACOKINETIC MODEL TO CHARACTERIZE CYCLOSPORINE BLOOD-CONCENTRATIONS AFTER ADMINISTRATIONS OF SANDIMMUNE OR NEORAL FORMULATIONS
Authors: DUCHARME MP VERRET L BROUILLETTE D SIROIS G
Citation: Mp. Ducharme et al., ABILITY OF A FIRST-PASS PHARMACOKINETIC MODEL TO CHARACTERIZE CYCLOSPORINE BLOOD-CONCENTRATIONS AFTER ADMINISTRATIONS OF SANDIMMUNE OR NEORAL FORMULATIONS, Therapeutic drug monitoring, 20(2), 1998, pp. 165-171
POPULATION PK OF CSA NEORAL(R) - SUPERIORITY OF A TIME-LAG FIRST-PASS2 CPT PK MODEL
Authors: VERRET L BROUILLETTE D SIROIS G CARRIER M WHITE M DUCHARME MP
Citation: L. Verret et al., POPULATION PK OF CSA NEORAL(R) - SUPERIORITY OF A TIME-LAG FIRST-PASS2 CPT PK MODEL, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 91-91
NONPARAMETRIC POPULATION PK OF CSA NEORAL(R) IN CARDIAC TRANSPLANT PATIENTS
Authors: BROUILLETTE D VERRET L SIROIS G CARRIER M WHITE M DUCHARME MP
Citation: D. Brouillette et al., NONPARAMETRIC POPULATION PK OF CSA NEORAL(R) IN CARDIAC TRANSPLANT PATIENTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 92-92
Risultati: 1-3 |